JL

Jit‑Min Lim

Chief Financial Officer

Lucence Diagnostics

Therapeutic Areas

Lucence Diagnostics Pipeline

DrugIndicationPhase
LiquidHALLMARKSolid Tumors (therapy selection & MRD)Commercial
LucenceINSIGHTMulti‑cancer early detection (up to 50 cancers)Commercial
LucenceLONGEVITYMulti‑disease screening (cancer + age‑related diseases)Commercial
UNITED 2.0Comprehensive tumor profiling (WES + WTS)Clinical Development